[Drug treatment of postmenopausal osteoporosis. What's New in 2006]

MeSH terms

• Absorptiometry, Photon
• Adult
• Age Factors
• Aged
• Aged, 80 and over
• Alendronate / administration & dosage
• Alendronate / therapeutic use
• Body Mass Index
• Bone Density
• Bone Density Conservation Agents / administration & dosage
• Bone Density Conservation Agents / therapeutic use*
• Bone Diseases, Metabolic / diagnosis
• Bone Diseases, Metabolic / therapy
• Female
• Femoral Fractures / etiology
• Femoral Fractures / prevention & control
• Follow-Up Studies
• Fractures, Bone / etiology
• Fractures, Bone / prevention & control
• Humans
• Middle Aged
• Organometallic Compounds / administration & dosage
• Organometallic Compounds / therapeutic use
• Osteoporosis, Postmenopausal / complications
• Osteoporosis, Postmenopausal / diagnosis
• Osteoporosis, Postmenopausal / drug therapy*
• Osteoporosis, Postmenopausal / prevention & control
• Practice Guidelines as Topic
• Raloxifene Hydrochloride / administration & dosage
• Raloxifene Hydrochloride / therapeutic use
• Risk Factors
• Spinal Fractures / etiology
• Spinal Fractures / prevention & control
• Tablets
• Teriparatide / administration & dosage
• Teriparatide / therapeutic use
• Thiophenes / administration & dosage
• Thiophenes / therapeutic use
• Time Factors